Long-term elution of antibiotics from bone-cement

An in vivo study using the prosthesis of antibiotic-loaded acrylic cement (PROSTALAC) system

Bassam A. Masri, Clive P. Duncan, Christopher P. Beauchamp

Research output: Contribution to journalArticle

229 Citations (Scopus)

Abstract

A prospective study of 49 patients undergoing a modified 2-stage exchange arthroplasty for infected total hip and knee arthroplasties using the prosthesis of antibiotic-loaded acrylic cement (PROSTALAC) system with a variety of doses of tobramycin and vancomycin was performed. The intra- articular concentrations of tobramycin and vancomycin were measured at the time of removal of the PROSTALAC temporary spacer and reimplantation of a definitive joint arthroplasty prosthesis, at a mean 118 days following initial implantation. The 95% confidence interval of the intra-articular concentration of tobramycin (4.35-123.88 mg/L) was entirely above the breakpoint sensitivity limit for sensitive organisms when at least 3.6 g of tobramycin was used per package of bone-cement but was entirely below it when at most 2.4 g was used. Vancomycin elution was not as good; however, detectable levels were still present in most patients. There was a statistically significant increase in the elution of vancomycin when the dose of tobramycin was increased from at most 2.4 g to at least 3.6 g. The dose of vancomycin in the cement did not influence the elution of either tobramycin or vancomycin. On the basis of these results, the use of at least 3.6 g of tobramycin and 1 g of vancomycin per package of bone-cement is recommended when antibiotic-loaded cement spacers are used in 2-stage exchange arthroplasty for infected total hip and knee arthroplasties.

Original languageEnglish (US)
Pages (from-to)331-338
Number of pages8
JournalJournal of Arthroplasty
Volume13
Issue number3
DOIs
StatePublished - Apr 1998
Externally publishedYes

Fingerprint

Bone Cements
Tobramycin
Vancomycin
Prostheses and Implants
Anti-Bacterial Agents
Arthroplasty
Knee Replacement Arthroplasties
Hip
Joints
Joint Prosthesis
Replantation
Prospective Studies
Confidence Intervals

Keywords

  • Antibiotic-loaded cement
  • Infected total hip arthroplasty
  • Infected total knee arthroplasty
  • PROSTALAC
  • Tobramycin elution
  • Vancomycin elution

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine
  • Surgery

Cite this

Long-term elution of antibiotics from bone-cement : An in vivo study using the prosthesis of antibiotic-loaded acrylic cement (PROSTALAC) system. / Masri, Bassam A.; Duncan, Clive P.; Beauchamp, Christopher P.

In: Journal of Arthroplasty, Vol. 13, No. 3, 04.1998, p. 331-338.

Research output: Contribution to journalArticle

@article{b460b3c8cc864a9cad878288898cc2d9,
title = "Long-term elution of antibiotics from bone-cement: An in vivo study using the prosthesis of antibiotic-loaded acrylic cement (PROSTALAC) system",
abstract = "A prospective study of 49 patients undergoing a modified 2-stage exchange arthroplasty for infected total hip and knee arthroplasties using the prosthesis of antibiotic-loaded acrylic cement (PROSTALAC) system with a variety of doses of tobramycin and vancomycin was performed. The intra- articular concentrations of tobramycin and vancomycin were measured at the time of removal of the PROSTALAC temporary spacer and reimplantation of a definitive joint arthroplasty prosthesis, at a mean 118 days following initial implantation. The 95{\%} confidence interval of the intra-articular concentration of tobramycin (4.35-123.88 mg/L) was entirely above the breakpoint sensitivity limit for sensitive organisms when at least 3.6 g of tobramycin was used per package of bone-cement but was entirely below it when at most 2.4 g was used. Vancomycin elution was not as good; however, detectable levels were still present in most patients. There was a statistically significant increase in the elution of vancomycin when the dose of tobramycin was increased from at most 2.4 g to at least 3.6 g. The dose of vancomycin in the cement did not influence the elution of either tobramycin or vancomycin. On the basis of these results, the use of at least 3.6 g of tobramycin and 1 g of vancomycin per package of bone-cement is recommended when antibiotic-loaded cement spacers are used in 2-stage exchange arthroplasty for infected total hip and knee arthroplasties.",
keywords = "Antibiotic-loaded cement, Infected total hip arthroplasty, Infected total knee arthroplasty, PROSTALAC, Tobramycin elution, Vancomycin elution",
author = "Masri, {Bassam A.} and Duncan, {Clive P.} and Beauchamp, {Christopher P.}",
year = "1998",
month = "4",
doi = "10.1016/S0883-5403(98)90179-6",
language = "English (US)",
volume = "13",
pages = "331--338",
journal = "Journal of Arthroplasty",
issn = "0883-5403",
publisher = "Churchill Livingstone",
number = "3",

}

TY - JOUR

T1 - Long-term elution of antibiotics from bone-cement

T2 - An in vivo study using the prosthesis of antibiotic-loaded acrylic cement (PROSTALAC) system

AU - Masri, Bassam A.

AU - Duncan, Clive P.

AU - Beauchamp, Christopher P.

PY - 1998/4

Y1 - 1998/4

N2 - A prospective study of 49 patients undergoing a modified 2-stage exchange arthroplasty for infected total hip and knee arthroplasties using the prosthesis of antibiotic-loaded acrylic cement (PROSTALAC) system with a variety of doses of tobramycin and vancomycin was performed. The intra- articular concentrations of tobramycin and vancomycin were measured at the time of removal of the PROSTALAC temporary spacer and reimplantation of a definitive joint arthroplasty prosthesis, at a mean 118 days following initial implantation. The 95% confidence interval of the intra-articular concentration of tobramycin (4.35-123.88 mg/L) was entirely above the breakpoint sensitivity limit for sensitive organisms when at least 3.6 g of tobramycin was used per package of bone-cement but was entirely below it when at most 2.4 g was used. Vancomycin elution was not as good; however, detectable levels were still present in most patients. There was a statistically significant increase in the elution of vancomycin when the dose of tobramycin was increased from at most 2.4 g to at least 3.6 g. The dose of vancomycin in the cement did not influence the elution of either tobramycin or vancomycin. On the basis of these results, the use of at least 3.6 g of tobramycin and 1 g of vancomycin per package of bone-cement is recommended when antibiotic-loaded cement spacers are used in 2-stage exchange arthroplasty for infected total hip and knee arthroplasties.

AB - A prospective study of 49 patients undergoing a modified 2-stage exchange arthroplasty for infected total hip and knee arthroplasties using the prosthesis of antibiotic-loaded acrylic cement (PROSTALAC) system with a variety of doses of tobramycin and vancomycin was performed. The intra- articular concentrations of tobramycin and vancomycin were measured at the time of removal of the PROSTALAC temporary spacer and reimplantation of a definitive joint arthroplasty prosthesis, at a mean 118 days following initial implantation. The 95% confidence interval of the intra-articular concentration of tobramycin (4.35-123.88 mg/L) was entirely above the breakpoint sensitivity limit for sensitive organisms when at least 3.6 g of tobramycin was used per package of bone-cement but was entirely below it when at most 2.4 g was used. Vancomycin elution was not as good; however, detectable levels were still present in most patients. There was a statistically significant increase in the elution of vancomycin when the dose of tobramycin was increased from at most 2.4 g to at least 3.6 g. The dose of vancomycin in the cement did not influence the elution of either tobramycin or vancomycin. On the basis of these results, the use of at least 3.6 g of tobramycin and 1 g of vancomycin per package of bone-cement is recommended when antibiotic-loaded cement spacers are used in 2-stage exchange arthroplasty for infected total hip and knee arthroplasties.

KW - Antibiotic-loaded cement

KW - Infected total hip arthroplasty

KW - Infected total knee arthroplasty

KW - PROSTALAC

KW - Tobramycin elution

KW - Vancomycin elution

UR - http://www.scopus.com/inward/record.url?scp=0031924774&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031924774&partnerID=8YFLogxK

U2 - 10.1016/S0883-5403(98)90179-6

DO - 10.1016/S0883-5403(98)90179-6

M3 - Article

VL - 13

SP - 331

EP - 338

JO - Journal of Arthroplasty

JF - Journal of Arthroplasty

SN - 0883-5403

IS - 3

ER -